

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.28677567 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 5.19183460 |
| 3 | vocalization behavior (GO:0071625) | 5.02006231 |
| 4 | neuronal action potential propagation (GO:0019227) | 4.96240794 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 4.78057391 |
| 6 | sodium ion export (GO:0071436) | 4.73917809 |
| 7 | glutamate secretion (GO:0014047) | 4.69428030 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.64659333 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.59368773 |
| 10 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.55690604 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.53283309 |
| 12 | locomotory exploration behavior (GO:0035641) | 4.48986572 |
| 13 | synaptic vesicle maturation (GO:0016188) | 4.44718038 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.34777385 |
| 15 | neurotransmitter secretion (GO:0007269) | 4.25814862 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.24619806 |
| 17 | protein localization to synapse (GO:0035418) | 4.23819050 |
| 18 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.20214871 |
| 19 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.19393319 |
| 20 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.10394047 |
| 21 | regulation of synaptic vesicle transport (GO:1902803) | 4.09014836 |
| 22 | glutamate receptor signaling pathway (GO:0007215) | 4.05831398 |
| 23 | potassium ion homeostasis (GO:0055075) | 4.05178683 |
| 24 | neuron-neuron synaptic transmission (GO:0007270) | 3.90503425 |
| 25 | potassium ion import (GO:0010107) | 3.83414537 |
| 26 | gamma-aminobutyric acid transport (GO:0015812) | 3.83158223 |
| 27 | presynaptic membrane assembly (GO:0097105) | 3.79622084 |
| 28 | regulation of ARF protein signal transduction (GO:0032012) | 3.79317879 |
| 29 | L-amino acid import (GO:0043092) | 3.78125797 |
| 30 | synaptic transmission, glutamatergic (GO:0035249) | 3.76759871 |
| 31 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.76443405 |
| 32 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.72544909 |
| 33 | exploration behavior (GO:0035640) | 3.70321991 |
| 34 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.65855587 |
| 35 | neurotransmitter transport (GO:0006836) | 3.62347591 |
| 36 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.54241905 |
| 37 | presynaptic membrane organization (GO:0097090) | 3.53654789 |
| 38 | long-term synaptic potentiation (GO:0060291) | 3.53300793 |
| 39 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.53129285 |
| 40 | neuron recognition (GO:0008038) | 3.52261876 |
| 41 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.51084781 |
| 42 | transmission of nerve impulse (GO:0019226) | 3.51081667 |
| 43 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.49699580 |
| 44 | mating behavior (GO:0007617) | 3.49182277 |
| 45 | central nervous system myelination (GO:0022010) | 3.48807394 |
| 46 | axon ensheathment in central nervous system (GO:0032291) | 3.48807394 |
| 47 | response to histamine (GO:0034776) | 3.46823301 |
| 48 | regulation of vesicle fusion (GO:0031338) | 3.45209941 |
| 49 | detection of calcium ion (GO:0005513) | 3.44835719 |
| 50 | cell communication by electrical coupling (GO:0010644) | 3.41157975 |
| 51 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.40463706 |
| 52 | regulation of postsynaptic membrane potential (GO:0060078) | 3.40198544 |
| 53 | regulation of neurotransmitter levels (GO:0001505) | 3.38846452 |
| 54 | cellular potassium ion homeostasis (GO:0030007) | 3.38080855 |
| 55 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.34793249 |
| 56 | long-term memory (GO:0007616) | 3.34754695 |
| 57 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.33934136 |
| 58 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.33066263 |
| 59 | cellular sodium ion homeostasis (GO:0006883) | 3.29039388 |
| 60 | proline transport (GO:0015824) | 3.20108328 |
| 61 | positive regulation of membrane potential (GO:0045838) | 3.18701855 |
| 62 | postsynaptic membrane organization (GO:0001941) | 3.17397188 |
| 63 | negative regulation of neurotransmitter transport (GO:0051589) | 3.16127382 |
| 64 | positive regulation of dendritic spine development (GO:0060999) | 3.15970782 |
| 65 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.15865191 |
| 66 | regulation of neurotransmitter secretion (GO:0046928) | 3.15358657 |
| 67 | regulation of synaptic plasticity (GO:0048167) | 3.13810911 |
| 68 | activation of protein kinase A activity (GO:0034199) | 3.13778480 |
| 69 | behavioral response to cocaine (GO:0048148) | 3.13648572 |
| 70 | amino acid import (GO:0043090) | 3.12795431 |
| 71 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.11545242 |
| 72 | neuromuscular process controlling posture (GO:0050884) | 3.10631943 |
| 73 | cerebellar granule cell differentiation (GO:0021707) | 3.09082358 |
| 74 | regulation of cell communication by electrical coupling (GO:0010649) | 3.08042498 |
| 75 | regulation of dendritic spine development (GO:0060998) | 3.07537308 |
| 76 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.07472274 |
| 77 | synaptic vesicle endocytosis (GO:0048488) | 3.06670611 |
| 78 | neuronal ion channel clustering (GO:0045161) | 3.06513378 |
| 79 | synapse assembly (GO:0007416) | 3.05958498 |
| 80 | chemosensory behavior (GO:0007635) | 3.05496245 |
| 81 | positive regulation of synapse maturation (GO:0090129) | 3.05487474 |
| 82 | membrane depolarization (GO:0051899) | 3.04203842 |
| 83 | membrane hyperpolarization (GO:0060081) | 3.03552264 |
| 84 | regulation of glutamate secretion (GO:0014048) | 3.01648247 |
| 85 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.00134427 |
| 86 | regulation of neurotransmitter transport (GO:0051588) | 2.98944808 |
| 87 | regulation of synapse structural plasticity (GO:0051823) | 2.98802662 |
| 88 | layer formation in cerebral cortex (GO:0021819) | 2.97420575 |
| 89 | neurotransmitter uptake (GO:0001504) | 2.96682772 |
| 90 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.95305578 |
| 91 | cell communication involved in cardiac conduction (GO:0086065) | 2.95159902 |
| 92 | synaptic transmission (GO:0007268) | 2.94357287 |
| 93 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.93165638 |
| 94 | axonal fasciculation (GO:0007413) | 2.92935389 |
| 95 | membrane depolarization during action potential (GO:0086010) | 2.90959121 |
| 96 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.90182263 |
| 97 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.86680962 |
| 98 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.86089926 |
| 99 | positive regulation of synapse assembly (GO:0051965) | 2.84127895 |
| 100 | positive regulation of neurotransmitter transport (GO:0051590) | 2.83518479 |
| 101 | fear response (GO:0042596) | 2.83265552 |
| 102 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.82762413 |
| 103 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.82762413 |
| 104 | social behavior (GO:0035176) | 2.82572618 |
| 105 | intraspecies interaction between organisms (GO:0051703) | 2.82572618 |
| 106 | positive regulation of synaptic transmission (GO:0050806) | 2.82514705 |
| 107 | striatum development (GO:0021756) | 2.82226895 |
| 108 | learning (GO:0007612) | 2.81370780 |
| 109 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.80777113 |
| 110 | startle response (GO:0001964) | 2.80561871 |
| 111 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.78436210 |
| 112 | regulation of protein kinase A signaling (GO:0010738) | 2.78252001 |
| 113 | adult walking behavior (GO:0007628) | 2.77766025 |
| 114 | regulation of synapse maturation (GO:0090128) | 2.77458895 |
| 115 | regulation of synaptic transmission (GO:0050804) | 2.76633708 |
| 116 | synapse organization (GO:0050808) | 2.76380275 |
| 117 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.76268147 |
| 118 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.76252506 |
| 119 | dendritic spine morphogenesis (GO:0060997) | 2.76179798 |
| 120 | establishment of synaptic vesicle localization (GO:0097480) | 2.75972846 |
| 121 | synaptic vesicle transport (GO:0048489) | 2.75972846 |
| 122 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.75523127 |
| 123 | behavioral fear response (GO:0001662) | 2.75423343 |
| 124 | behavioral defense response (GO:0002209) | 2.75423343 |
| 125 | neuromuscular process controlling balance (GO:0050885) | 2.74002175 |
| 126 | signal release (GO:0023061) | 2.72911917 |
| 127 | positive regulation of Rap GTPase activity (GO:0032854) | 2.70916136 |
| 128 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.70214856 |
| 129 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.69759666 |
| 130 | regulation of exocytosis (GO:0017157) | 2.60779915 |
| 131 | regulation of beta-amyloid formation (GO:1902003) | 2.60189308 |
| 132 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.59977312 |
| 133 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.59646847 |
| 134 | relaxation of cardiac muscle (GO:0055119) | 2.59241329 |
| 135 | cardiac conduction (GO:0061337) | 2.56374641 |
| 136 | insulin secretion (GO:0030073) | 2.56141770 |
| 137 | myelin maintenance (GO:0043217) | 2.53519686 |
| 138 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.53308629 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.71481341 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.78187113 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.09080714 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.05010399 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.90634890 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.62364146 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.59706536 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.52221729 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.52221729 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.49263302 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.49189179 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.45200463 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.44199806 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.42398858 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.38403559 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.27901486 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.19170012 |
| 18 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.14899814 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.07606045 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.04668300 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.03410405 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.01869121 |
| 23 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.97632560 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.96851326 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.91644536 |
| 26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.89732992 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.89498176 |
| 28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.85983597 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.84031621 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.83588879 |
| 31 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.82860810 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.80842494 |
| 33 | P300_19829295_ChIP-Seq_ESCs_Human | 1.73547016 |
| 34 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.66313129 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.64807908 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60370585 |
| 37 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.59629107 |
| 38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.59207750 |
| 39 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.58189411 |
| 40 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.57507405 |
| 41 | VDR_22108803_ChIP-Seq_LS180_Human | 1.56393037 |
| 42 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.55426073 |
| 43 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.54599801 |
| 44 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.52154238 |
| 45 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45599313 |
| 46 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.45290491 |
| 47 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43853915 |
| 48 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43418384 |
| 49 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.40891077 |
| 50 | AR_25329375_ChIP-Seq_VCAP_Human | 1.40623138 |
| 51 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.40558647 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.39227780 |
| 53 | FUS_26573619_Chip-Seq_HEK293_Human | 1.39179698 |
| 54 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.33753235 |
| 55 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.33247954 |
| 56 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.32955656 |
| 57 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.29973303 |
| 58 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.28582152 |
| 59 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.28153962 |
| 60 | STAT3_23295773_ChIP-Seq_U87_Human | 1.26180772 |
| 61 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25709553 |
| 62 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23328248 |
| 63 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.22826326 |
| 64 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22642044 |
| 65 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.20897685 |
| 66 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.20762684 |
| 67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19925486 |
| 68 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.19815689 |
| 69 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.19475476 |
| 70 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.18144709 |
| 71 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.17530513 |
| 72 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17484963 |
| 73 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.16909154 |
| 74 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13575994 |
| 75 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.13067828 |
| 76 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.12827858 |
| 77 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11693929 |
| 78 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.11501918 |
| 79 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.10906209 |
| 80 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09373219 |
| 81 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09271317 |
| 82 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07519010 |
| 83 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07157855 |
| 84 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06083456 |
| 85 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05616146 |
| 86 | AR_19668381_ChIP-Seq_PC3_Human | 1.05309783 |
| 87 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.02781767 |
| 88 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.02113631 |
| 89 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01370529 |
| 90 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01089209 |
| 91 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99305782 |
| 92 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98098539 |
| 93 | JUN_21703547_ChIP-Seq_K562_Human | 0.97680526 |
| 94 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.97524602 |
| 95 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.97367088 |
| 96 | TP53_16413492_ChIP-PET_HCT116_Human | 0.97366077 |
| 97 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96884920 |
| 98 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.96549605 |
| 99 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96330583 |
| 100 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.96114522 |
| 101 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95535389 |
| 102 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95453552 |
| 103 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.94863092 |
| 104 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91971701 |
| 105 | KDM2B_26808549_Chip-Seq_REH_Human | 0.91782121 |
| 106 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91403320 |
| 107 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.91325121 |
| 108 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.89655826 |
| 109 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.89477448 |
| 110 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.89268648 |
| 111 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89268648 |
| 112 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.88978569 |
| 113 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.88617379 |
| 114 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.88082636 |
| 115 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87988471 |
| 116 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.87772974 |
| 117 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.87673231 |
| 118 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87621231 |
| 119 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.87577661 |
| 120 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.87455975 |
| 121 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.87249921 |
| 122 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.87216205 |
| 123 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87068311 |
| 124 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.86777349 |
| 125 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.85912390 |
| 126 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84804132 |
| 127 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84804132 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.20130340 |
| 2 | MP0003880_abnormal_central_pattern | 5.09936896 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.87866167 |
| 4 | MP0009745_abnormal_behavioral_response | 3.39244375 |
| 5 | MP0009046_muscle_twitch | 3.29711964 |
| 6 | MP0004270_analgesia | 3.29329181 |
| 7 | MP0002064_seizures | 3.24859798 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.14732930 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.00089082 |
| 10 | MP0002272_abnormal_nervous_system | 2.79220777 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.75672017 |
| 12 | MP0002736_abnormal_nociception_after | 2.64240508 |
| 13 | MP0001501_abnormal_sleep_pattern | 2.61912482 |
| 14 | MP0001486_abnormal_startle_reflex | 2.56714785 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.54161532 |
| 16 | MP0002822_catalepsy | 2.50411782 |
| 17 | MP0001440_abnormal_grooming_behavior | 2.33363508 |
| 18 | MP0005423_abnormal_somatic_nervous | 2.28086325 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.25598645 |
| 20 | MP0002067_abnormal_sensory_capabilities | 2.12708586 |
| 21 | MP0006276_abnormal_autonomic_nervous | 2.07707295 |
| 22 | MP0002733_abnormal_thermal_nociception | 1.99851322 |
| 23 | MP0001970_abnormal_pain_threshold | 1.95591377 |
| 24 | MP0001529_abnormal_vocalization | 1.92449462 |
| 25 | MP0005386_behavior/neurological_phenoty | 1.90153136 |
| 26 | MP0004924_abnormal_behavior | 1.90153136 |
| 27 | MP0001905_abnormal_dopamine_level | 1.84730012 |
| 28 | MP0009780_abnormal_chondrocyte_physiolo | 1.84616433 |
| 29 | MP0003329_amyloid_beta_deposits | 1.79283870 |
| 30 | MP0002184_abnormal_innervation | 1.71782449 |
| 31 | MP0004142_abnormal_muscle_tone | 1.69944723 |
| 32 | MP0001984_abnormal_olfaction | 1.69880337 |
| 33 | MP0008569_lethality_at_weaning | 1.69802683 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.67247670 |
| 35 | MP0002909_abnormal_adrenal_gland | 1.62075705 |
| 36 | MP0002837_dystrophic_cardiac_calcinosis | 1.56634365 |
| 37 | MP0005646_abnormal_pituitary_gland | 1.54120652 |
| 38 | MP0001188_hyperpigmentation | 1.49131536 |
| 39 | MP0000778_abnormal_nervous_system | 1.48998635 |
| 40 | MP0000569_abnormal_digit_pigmentation | 1.47665149 |
| 41 | MP0004145_abnormal_muscle_electrophysio | 1.41332113 |
| 42 | MP0002066_abnormal_motor_capabilities/c | 1.38785577 |
| 43 | MP0000955_abnormal_spinal_cord | 1.36867827 |
| 44 | MP0003879_abnormal_hair_cell | 1.36636450 |
| 45 | MP0004811_abnormal_neuron_physiology | 1.32690843 |
| 46 | MP0001502_abnormal_circadian_rhythm | 1.30337374 |
| 47 | MP0003122_maternal_imprinting | 1.29400566 |
| 48 | MP0000013_abnormal_adipose_tissue | 1.29190970 |
| 49 | MP0004885_abnormal_endolymph | 1.28106121 |
| 50 | MP0010234_abnormal_vibrissa_follicle | 1.27906867 |
| 51 | MP0010386_abnormal_urinary_bladder | 1.27862130 |
| 52 | MP0003633_abnormal_nervous_system | 1.27617389 |
| 53 | MP0002882_abnormal_neuron_morphology | 1.26839605 |
| 54 | MP0003123_paternal_imprinting | 1.25904739 |
| 55 | MP0003283_abnormal_digestive_organ | 1.23282327 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.20990990 |
| 57 | MP0005645_abnormal_hypothalamus_physiol | 1.19286584 |
| 58 | MP0005535_abnormal_body_temperature | 1.16448899 |
| 59 | MP0004130_abnormal_muscle_cell | 1.14617931 |
| 60 | MP0004858_abnormal_nervous_system | 1.13560696 |
| 61 | MP0004742_abnormal_vestibular_system | 1.13477597 |
| 62 | MP0002876_abnormal_thyroid_physiology | 1.10768510 |
| 63 | MP0005551_abnormal_eye_electrophysiolog | 1.10548239 |
| 64 | MP0004510_myositis | 1.10468142 |
| 65 | MP0008872_abnormal_physiological_respon | 1.08604636 |
| 66 | MP0002229_neurodegeneration | 1.07783884 |
| 67 | MP0003631_nervous_system_phenotype | 1.07757710 |
| 68 | MP0003045_fibrosis | 1.01993288 |
| 69 | MP0003787_abnormal_imprinting | 1.01679560 |
| 70 | MP0004043_abnormal_pH_regulation | 1.00919836 |
| 71 | MP0000920_abnormal_myelination | 0.99034781 |
| 72 | MP0003690_abnormal_glial_cell | 0.98784613 |
| 73 | MP0008874_decreased_physiological_sensi | 0.97016279 |
| 74 | MP0000751_myopathy | 0.94998105 |
| 75 | MP0003183_abnormal_peptide_metabolism | 0.94549682 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 0.91225117 |
| 77 | MP0002152_abnormal_brain_morphology | 0.89521297 |
| 78 | MP0001963_abnormal_hearing_physiology | 0.89324867 |
| 79 | MP0004085_abnormal_heartbeat | 0.88934991 |
| 80 | MP0002069_abnormal_eating/drinking_beha | 0.88815587 |
| 81 | MP0004484_altered_response_of | 0.87741983 |
| 82 | MP0000604_amyloidosis | 0.86997712 |
| 83 | MP0005409_darkened_coat_color | 0.86340969 |
| 84 | MP0000003_abnormal_adipose_tissue | 0.85474843 |
| 85 | MP0003634_abnormal_glial_cell | 0.85089109 |
| 86 | MP0004215_abnormal_myocardial_fiber | 0.84622350 |
| 87 | MP0001664_abnormal_digestion | 0.82968739 |
| 88 | MP0010329_abnormal_lipoprotein_level | 0.82311221 |
| 89 | MP0001944_abnormal_pancreas_morphology | 0.82204913 |
| 90 | MP0002078_abnormal_glucose_homeostasis | 0.81504674 |
| 91 | MP0001177_atelectasis | 0.80060423 |
| 92 | MP0002090_abnormal_vision | 0.79731579 |
| 93 | MP0001986_abnormal_taste_sensitivity | 0.78989141 |
| 94 | MP0001485_abnormal_pinna_reflex | 0.77438804 |
| 95 | MP0003632_abnormal_nervous_system | 0.76893379 |
| 96 | MP0002971_abnormal_brown_adipose | 0.72974252 |
| 97 | MP0002752_abnormal_somatic_nervous | 0.72129560 |
| 98 | MP0005379_endocrine/exocrine_gland_phen | 0.70268731 |
| 99 | MP0000631_abnormal_neuroendocrine_gland | 0.70051238 |
| 100 | MP0004036_abnormal_muscle_relaxation | 0.69766473 |
| 101 | MP0002693_abnormal_pancreas_physiology | 0.69283671 |
| 102 | MP0006072_abnormal_retinal_apoptosis | 0.67814718 |
| 103 | MP0003195_calcinosis | 0.67785195 |
| 104 | MP0001958_emphysema | 0.65764793 |
| 105 | MP0000639_abnormal_adrenal_gland | 0.63714295 |
| 106 | MP0001765_abnormal_ion_homeostasis | 0.63555223 |
| 107 | MP0008877_abnormal_DNA_methylation | 0.63340162 |
| 108 | MP0005166_decreased_susceptibility_to | 0.63255986 |
| 109 | MP0001756_abnormal_urination | 0.62402616 |
| 110 | MP0002638_abnormal_pupillary_reflex | 0.61939329 |
| 111 | MP0005394_taste/olfaction_phenotype | 0.61619448 |
| 112 | MP0005499_abnormal_olfactory_system | 0.61619448 |
| 113 | MP0003137_abnormal_impulse_conducting | 0.61341565 |
| 114 | MP0005171_absent_coat_pigmentation | 0.60516532 |
| 115 | MP0000747_muscle_weakness | 0.58247861 |
| 116 | MP0001943_abnormal_respiration | 0.57105049 |
| 117 | MP0006035_abnormal_mitochondrial_morpho | 0.54633971 |
| 118 | MP0000230_abnormal_systemic_arterial | 0.52231579 |
| 119 | MP0000026_abnormal_inner_ear | 0.49612022 |
| 120 | MP0003075_altered_response_to | 0.48458004 |
| 121 | MP0005623_abnormal_meninges_morphology | 0.48263947 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.18955983 |
| 2 | Atonic seizures (HP:0010819) | 5.69946635 |
| 3 | Focal seizures (HP:0007359) | 5.67356319 |
| 4 | Myokymia (HP:0002411) | 5.48924197 |
| 5 | Visual hallucinations (HP:0002367) | 5.11971261 |
| 6 | Absence seizures (HP:0002121) | 4.82866450 |
| 7 | Epileptic encephalopathy (HP:0200134) | 4.79692660 |
| 8 | Febrile seizures (HP:0002373) | 4.44929874 |
| 9 | Dialeptic seizures (HP:0011146) | 4.39439634 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 4.13536297 |
| 11 | Hyperventilation (HP:0002883) | 4.13343657 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.99558785 |
| 13 | Broad-based gait (HP:0002136) | 3.62856341 |
| 14 | Bundle branch block (HP:0011710) | 3.60046248 |
| 15 | Ventricular fibrillation (HP:0001663) | 3.38456496 |
| 16 | Increased circulating renin level (HP:0000848) | 3.35139007 |
| 17 | Action tremor (HP:0002345) | 3.19169851 |
| 18 | Scanning speech (HP:0002168) | 3.19131379 |
| 19 | Gaze-evoked nystagmus (HP:0000640) | 3.15683156 |
| 20 | Obstructive sleep apnea (HP:0002870) | 3.09296808 |
| 21 | Anxiety (HP:0000739) | 3.07315087 |
| 22 | Dysdiadochokinesis (HP:0002075) | 3.01723262 |
| 23 | Dysmetria (HP:0001310) | 2.99909613 |
| 24 | Pheochromocytoma (HP:0002666) | 2.99851371 |
| 25 | Supranuclear gaze palsy (HP:0000605) | 2.99175757 |
| 26 | Poor eye contact (HP:0000817) | 2.98431594 |
| 27 | Progressive inability to walk (HP:0002505) | 2.91806059 |
| 28 | Amblyopia (HP:0000646) | 2.91545104 |
| 29 | Hemiplegia (HP:0002301) | 2.85571048 |
| 30 | Truncal ataxia (HP:0002078) | 2.85259960 |
| 31 | Akinesia (HP:0002304) | 2.82603503 |
| 32 | Limb dystonia (HP:0002451) | 2.79922358 |
| 33 | Impaired social interactions (HP:0000735) | 2.79814587 |
| 34 | Abnormal social behavior (HP:0012433) | 2.79814587 |
| 35 | Tetraplegia (HP:0002445) | 2.74764948 |
| 36 | Neuroendocrine neoplasm (HP:0100634) | 2.73494002 |
| 37 | Abnormal eating behavior (HP:0100738) | 2.73418856 |
| 38 | Depression (HP:0000716) | 2.73369445 |
| 39 | Neurofibrillary tangles (HP:0002185) | 2.70713387 |
| 40 | Cerebral inclusion bodies (HP:0100314) | 2.70688459 |
| 41 | Syncope (HP:0001279) | 2.60735912 |
| 42 | Drooling (HP:0002307) | 2.59814960 |
| 43 | Excessive salivation (HP:0003781) | 2.59814960 |
| 44 | Epileptiform EEG discharges (HP:0011182) | 2.56192725 |
| 45 | Status epilepticus (HP:0002133) | 2.54995787 |
| 46 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.54028089 |
| 47 | Rigidity (HP:0002063) | 2.49979596 |
| 48 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.47923912 |
| 49 | Absent speech (HP:0001344) | 2.45135821 |
| 50 | Abnormality of binocular vision (HP:0011514) | 2.44505861 |
| 51 | Diplopia (HP:0000651) | 2.44505861 |
| 52 | Abnormal EKG (HP:0003115) | 2.42375555 |
| 53 | EEG with generalized epileptiform discharges (HP:0011198) | 2.42101968 |
| 54 | Hypoglycemic seizures (HP:0002173) | 2.41609470 |
| 55 | Papilledema (HP:0001085) | 2.39515982 |
| 56 | Inability to walk (HP:0002540) | 2.38756305 |
| 57 | Generalized myoclonic seizures (HP:0002123) | 2.37416736 |
| 58 | Prolonged QT interval (HP:0001657) | 2.36224415 |
| 59 | Heart block (HP:0012722) | 2.34492663 |
| 60 | Gait imbalance (HP:0002141) | 2.31659126 |
| 61 | Intention tremor (HP:0002080) | 2.31581810 |
| 62 | Blue irides (HP:0000635) | 2.30461162 |
| 63 | Hemiparesis (HP:0001269) | 2.27187543 |
| 64 | Hyporeflexia of lower limbs (HP:0002600) | 2.26614623 |
| 65 | Ankle clonus (HP:0011448) | 2.26248852 |
| 66 | Psychosis (HP:0000709) | 2.25975046 |
| 67 | Acute necrotizing encephalopathy (HP:0006965) | 2.25196808 |
| 68 | Craniofacial dystonia (HP:0012179) | 2.24257960 |
| 69 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.24175898 |
| 70 | Hypsarrhythmia (HP:0002521) | 2.21857815 |
| 71 | Impaired smooth pursuit (HP:0007772) | 2.21746588 |
| 72 | Postural instability (HP:0002172) | 2.21463534 |
| 73 | Spastic gait (HP:0002064) | 2.21178012 |
| 74 | Lower limb muscle weakness (HP:0007340) | 2.20065650 |
| 75 | Agitation (HP:0000713) | 2.16864117 |
| 76 | Neuronal loss in central nervous system (HP:0002529) | 2.16758219 |
| 77 | Sudden death (HP:0001699) | 2.15953021 |
| 78 | Abnormal atrioventricular conduction (HP:0005150) | 2.15810970 |
| 79 | Fetal akinesia sequence (HP:0001989) | 2.14221246 |
| 80 | Postural tremor (HP:0002174) | 2.14128132 |
| 81 | Termporal pattern (HP:0011008) | 2.14085066 |
| 82 | Insidious onset (HP:0003587) | 2.14085066 |
| 83 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.13336725 |
| 84 | Genetic anticipation (HP:0003743) | 2.13040928 |
| 85 | Progressive macrocephaly (HP:0004481) | 2.12411895 |
| 86 | Protruding tongue (HP:0010808) | 2.10109649 |
| 87 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.09296971 |
| 88 | Abnormality of the corticospinal tract (HP:0002492) | 2.08904317 |
| 89 | Polyphagia (HP:0002591) | 2.07908507 |
| 90 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.07513301 |
| 91 | Absent/shortened dynein arms (HP:0200106) | 2.07513301 |
| 92 | Stereotypic behavior (HP:0000733) | 2.06227375 |
| 93 | Congenital primary aphakia (HP:0007707) | 2.06111181 |
| 94 | Bradykinesia (HP:0002067) | 2.06056451 |
| 95 | Fair hair (HP:0002286) | 2.05657709 |
| 96 | Abnormal ciliary motility (HP:0012262) | 2.05361108 |
| 97 | Hypoglycemic coma (HP:0001325) | 2.03896442 |
| 98 | Metaphyseal dysplasia (HP:0100255) | 2.03813199 |
| 99 | Spastic tetraparesis (HP:0001285) | 2.03648763 |
| 100 | Hyperglycemia (HP:0003074) | 2.03351405 |
| 101 | Urinary urgency (HP:0000012) | 2.03151465 |
| 102 | Ventricular arrhythmia (HP:0004308) | 2.02512815 |
| 103 | Clonus (HP:0002169) | 2.02408035 |
| 104 | Annular pancreas (HP:0001734) | 2.02242519 |
| 105 | Medial flaring of the eyebrow (HP:0010747) | 2.01561289 |
| 106 | Generalized hypopigmentation of hair (HP:0011358) | 2.01278659 |
| 107 | Abnormal hair whorl (HP:0010721) | 1.99174647 |
| 108 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.99087006 |
| 109 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.98163223 |
| 110 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.98163223 |
| 111 | Gait ataxia (HP:0002066) | 1.97684598 |
| 112 | Sleep apnea (HP:0010535) | 1.97360948 |
| 113 | Diminished movement (HP:0002374) | 1.95023345 |
| 114 | Mutism (HP:0002300) | 1.94625104 |
| 115 | Torticollis (HP:0000473) | 1.93500641 |
| 116 | Failure to thrive in infancy (HP:0001531) | 1.92694766 |
| 117 | Abnormality of saccadic eye movements (HP:0000570) | 1.91649759 |
| 118 | Retinal dysplasia (HP:0007973) | 1.91546524 |
| 119 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.91096833 |
| 120 | Impaired vibratory sensation (HP:0002495) | 1.90971323 |
| 121 | Dysmetric saccades (HP:0000641) | 1.90966486 |
| 122 | Clumsiness (HP:0002312) | 1.89456378 |
| 123 | Focal dystonia (HP:0004373) | 1.88463116 |
| 124 | Ketoacidosis (HP:0001993) | 1.88248350 |
| 125 | Nephrogenic diabetes insipidus (HP:0009806) | 1.87071882 |
| 126 | Apathy (HP:0000741) | 1.86946342 |
| 127 | Rapidly progressive (HP:0003678) | 1.85601310 |
| 128 | Cerebral hemorrhage (HP:0001342) | 1.85389156 |
| 129 | Specific learning disability (HP:0001328) | 1.84950857 |
| 130 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.83381315 |
| 131 | Genital tract atresia (HP:0001827) | 1.83324385 |
| 132 | Abnormality of salivation (HP:0100755) | 1.83225533 |
| 133 | Hypothermia (HP:0002045) | 1.81770278 |
| 134 | Acute encephalopathy (HP:0006846) | 1.81670512 |
| 135 | Vaginal atresia (HP:0000148) | 1.81023817 |
| 136 | Resting tremor (HP:0002322) | 1.80935349 |
| 137 | Delusions (HP:0000746) | 1.80720090 |
| 138 | Thickened helices (HP:0000391) | 1.80564869 |
| 139 | Difficulty running (HP:0009046) | 1.80524057 |
| 140 | Choreoathetosis (HP:0001266) | 1.79841994 |
| 141 | Exercise-induced myalgia (HP:0003738) | 1.79580628 |
| 142 | Heterochromia iridis (HP:0001100) | 1.79322944 |
| 143 | Atrial fibrillation (HP:0005110) | 1.78881041 |
| 144 | Cerebral hypomyelination (HP:0006808) | 1.78188285 |
| 145 | Atrioventricular block (HP:0001678) | 1.76103869 |
| 146 | Menstrual irregularities (HP:0000858) | 1.75773097 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.26293398 |
| 2 | EPHA4 | 3.90902732 |
| 3 | MAP3K9 | 3.08332839 |
| 4 | MAP3K12 | 2.91595121 |
| 5 | MAP3K4 | 2.84079372 |
| 6 | MAP2K7 | 2.71201974 |
| 7 | CASK | 2.60728696 |
| 8 | PNCK | 2.50701918 |
| 9 | RIPK4 | 2.47195414 |
| 10 | MINK1 | 2.34365793 |
| 11 | MAP2K4 | 2.16087825 |
| 12 | DAPK2 | 2.07599204 |
| 13 | KSR2 | 1.90275037 |
| 14 | TNIK | 1.86553327 |
| 15 | NTRK1 | 1.83948365 |
| 16 | MARK1 | 1.83259564 |
| 17 | GRK5 | 1.83145080 |
| 18 | CDK19 | 1.74666553 |
| 19 | FRK | 1.73865027 |
| 20 | PLK2 | 1.71901677 |
| 21 | PAK6 | 1.67772497 |
| 22 | OXSR1 | 1.64753361 |
| 23 | NTRK2 | 1.62118890 |
| 24 | FGFR2 | 1.59958411 |
| 25 | ARAF | 1.59642507 |
| 26 | BMPR2 | 1.55629788 |
| 27 | LATS2 | 1.50350094 |
| 28 | CDK5 | 1.39179341 |
| 29 | STK39 | 1.38109663 |
| 30 | MAP3K13 | 1.31446513 |
| 31 | DAPK1 | 1.28508528 |
| 32 | CAMKK2 | 1.26853785 |
| 33 | MAP3K2 | 1.25883073 |
| 34 | RIPK1 | 1.25554914 |
| 35 | CAMKK1 | 1.23090655 |
| 36 | CAMK2A | 1.20660932 |
| 37 | FES | 1.19955843 |
| 38 | PRKCG | 1.18576166 |
| 39 | KSR1 | 1.17692896 |
| 40 | MAPKAPK5 | 1.16954793 |
| 41 | MAPK13 | 1.15129509 |
| 42 | CAMK2B | 1.11410860 |
| 43 | SIK2 | 1.10608551 |
| 44 | PRPF4B | 1.07196109 |
| 45 | UHMK1 | 1.06881277 |
| 46 | NME1 | 1.05181831 |
| 47 | WNK4 | 1.04664875 |
| 48 | FGFR3 | 1.02357411 |
| 49 | TNK2 | 1.00118528 |
| 50 | STK38 | 0.99627121 |
| 51 | PINK1 | 0.96861783 |
| 52 | SGK494 | 0.92684899 |
| 53 | SGK223 | 0.92684899 |
| 54 | PTK2B | 0.90172032 |
| 55 | PRKD3 | 0.89947165 |
| 56 | WNK1 | 0.89458816 |
| 57 | CAMK2D | 0.88057378 |
| 58 | CSNK1G2 | 0.87883681 |
| 59 | JAK1 | 0.86592961 |
| 60 | PAK3 | 0.84989289 |
| 61 | AKT3 | 0.83044220 |
| 62 | PHKG1 | 0.78706481 |
| 63 | PHKG2 | 0.78706481 |
| 64 | CAMK1 | 0.77489880 |
| 65 | MAPK10 | 0.76731918 |
| 66 | RET | 0.76500003 |
| 67 | GRK7 | 0.75923471 |
| 68 | CDK14 | 0.75385178 |
| 69 | HIPK2 | 0.75087176 |
| 70 | PRKCE | 0.72468976 |
| 71 | CAMK2G | 0.72255660 |
| 72 | MAP3K1 | 0.72139396 |
| 73 | SGK2 | 0.71834749 |
| 74 | INSRR | 0.70681856 |
| 75 | PRKCH | 0.70155195 |
| 76 | MUSK | 0.69817424 |
| 77 | OBSCN | 0.69587813 |
| 78 | CDK18 | 0.68659855 |
| 79 | STK38L | 0.67624006 |
| 80 | CDK15 | 0.66474056 |
| 81 | STK11 | 0.66415020 |
| 82 | SGK1 | 0.65146913 |
| 83 | CAMK4 | 0.65037980 |
| 84 | RAF1 | 0.64033937 |
| 85 | FGR | 0.63416020 |
| 86 | ALK | 0.62671243 |
| 87 | CCNB1 | 0.62427164 |
| 88 | MAP3K6 | 0.58959794 |
| 89 | TYRO3 | 0.58749459 |
| 90 | PDPK1 | 0.57718672 |
| 91 | PDK1 | 0.57661475 |
| 92 | CDK11A | 0.56507595 |
| 93 | FER | 0.56429393 |
| 94 | LIMK1 | 0.55475841 |
| 95 | BCR | 0.54438938 |
| 96 | MAP2K1 | 0.54141162 |
| 97 | DYRK1A | 0.52082564 |
| 98 | ROCK1 | 0.49318553 |
| 99 | LMTK2 | 0.48768869 |
| 100 | CSNK1G3 | 0.47819795 |
| 101 | ROCK2 | 0.46924396 |
| 102 | WNK3 | 0.46519945 |
| 103 | MAP2K6 | 0.46386742 |
| 104 | PRKG1 | 0.45825989 |
| 105 | IRAK2 | 0.45788623 |
| 106 | PRKACA | 0.45508961 |
| 107 | MAP3K7 | 0.45423559 |
| 108 | PRKD1 | 0.44735672 |
| 109 | SGK3 | 0.43540617 |
| 110 | MARK2 | 0.42091243 |
| 111 | NEK9 | 0.41358796 |
| 112 | ADRBK2 | 0.41255844 |
| 113 | PKN1 | 0.40723437 |
| 114 | RPS6KA3 | 0.40375315 |
| 115 | ADRBK1 | 0.39710696 |
| 116 | BRAF | 0.39307483 |
| 117 | PRKG2 | 0.38566812 |
| 118 | PRKCZ | 0.38337411 |
| 119 | NEK6 | 0.37704633 |
| 120 | MAPK7 | 0.37299907 |
| 121 | JAK2 | 0.36878424 |
| 122 | RPS6KB1 | 0.36323261 |
| 123 | PRKCA | 0.36319059 |
| 124 | CAMK1G | 0.35973022 |
| 125 | MAPK12 | 0.35863786 |
| 126 | FYN | 0.35758925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.88665007 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.22990821 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.79539859 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.76172053 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.60728525 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.49903200 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.46268798 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.44937839 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.44905473 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.34650570 |
| 11 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.23961824 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.12139686 |
| 13 | Taste transduction_Homo sapiens_hsa04742 | 2.10013400 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.08260592 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.94729884 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.93370830 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.88978225 |
| 18 | Long-term depression_Homo sapiens_hsa04730 | 1.85610089 |
| 19 | Renin secretion_Homo sapiens_hsa04924 | 1.85252204 |
| 20 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.79333268 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.78018350 |
| 22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.72111270 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.64713267 |
| 24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.59575502 |
| 25 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.57319510 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.53655551 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.50117933 |
| 28 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.45512306 |
| 29 | Alzheimers disease_Homo sapiens_hsa05010 | 1.45328410 |
| 30 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.43052658 |
| 31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.37413384 |
| 32 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.36891645 |
| 33 | Parkinsons disease_Homo sapiens_hsa05012 | 1.36854395 |
| 34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.34935712 |
| 35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.30371367 |
| 36 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.25682308 |
| 37 | Gap junction_Homo sapiens_hsa04540 | 1.23862363 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.21617084 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.21609490 |
| 40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.16645051 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.09888048 |
| 42 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08145284 |
| 43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01225823 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.01031491 |
| 45 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.00604529 |
| 46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.99462796 |
| 47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.97803053 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94095108 |
| 49 | Phototransduction_Homo sapiens_hsa04744 | 0.92464095 |
| 50 | Histidine metabolism_Homo sapiens_hsa00340 | 0.87129735 |
| 51 | Melanogenesis_Homo sapiens_hsa04916 | 0.84065038 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83784034 |
| 53 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.80688351 |
| 54 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.79986598 |
| 55 | Huntingtons disease_Homo sapiens_hsa05016 | 0.79735252 |
| 56 | Axon guidance_Homo sapiens_hsa04360 | 0.78783984 |
| 57 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77184562 |
| 58 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.77123261 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75255506 |
| 60 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74657519 |
| 61 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.74082348 |
| 62 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73888167 |
| 63 | Mineral absorption_Homo sapiens_hsa04978 | 0.72760102 |
| 64 | Glioma_Homo sapiens_hsa05214 | 0.72264241 |
| 65 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.63443220 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62476077 |
| 67 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.60974698 |
| 68 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.59716112 |
| 69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59545179 |
| 70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58895270 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57887625 |
| 72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57029629 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57015484 |
| 74 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55871523 |
| 75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.55378544 |
| 76 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55205528 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54952440 |
| 78 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.54391894 |
| 79 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.53769497 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51934870 |
| 81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51545173 |
| 82 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.50768100 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.50722519 |
| 84 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.49089061 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.48985553 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48835361 |
| 87 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.48738548 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48156414 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.46661734 |
| 90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46649406 |
| 91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45821428 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45007304 |
| 93 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43761025 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43376220 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43312423 |
| 96 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.41249493 |
| 97 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.39718542 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.39516397 |
| 99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.38980569 |
| 100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38476134 |
| 101 | ABC transporters_Homo sapiens_hsa02010 | 0.38037241 |
| 102 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.37157168 |
| 103 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36103293 |
| 104 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35246504 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34486941 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34178410 |
| 107 | Alcoholism_Homo sapiens_hsa05034 | 0.34092475 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33662702 |
| 109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.32622436 |
| 110 | Circadian rhythm_Homo sapiens_hsa04710 | 0.32118246 |
| 111 | Tight junction_Homo sapiens_hsa04530 | 0.31905706 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31506314 |
| 113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31393828 |
| 114 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31304351 |
| 115 | Insulin resistance_Homo sapiens_hsa04931 | 0.30697913 |
| 116 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30156892 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29874384 |
| 118 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.28292098 |
| 119 | Endometrial cancer_Homo sapiens_hsa05213 | 0.28240503 |
| 120 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.23793779 |
| 121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.23265306 |
| 122 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.21760760 |
| 123 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.19595663 |
| 124 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.18638909 |

